Phoenix Financial Ltd.

Position in NVO — Novo Nordisk A S

CIK 1679543 Givatayim, L3

Position in NVO

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$7,590,962

+$3,814,459 QoQ

Shares Held

158,343

+54.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#171

of 1,348 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Phoenix Financial Ltd. holds $174,300,668 across 10 Drug Manufacturers - General names. NVO ranks #4 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	97,019	$116,367,508
2	ABBV	AbbVie Inc.	47,441	$11,938,053
3	JNJ	Johnson & Johnson	46,830	$11,893,414
4	NVO	Novo Nordisk A S This page	158,343	$7,590,962
5	MRK	Merck & Co., Inc.	52,551	$6,752,803
6	BMY	Bristol Myers Squibb Co	114,254	$6,583,314
7	PFE	Pfizer Inc	253,976	$6,115,741
8	AZN	Astrazeneca PLC	19,365	$3,671,991

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,590,962	158,343	+54.1%	Shares	Sole	2026-08-11
2026-03-31	$3,776,503	102,762	-15.9%	Shares	Sole	2026-05-11
2025-12-31	$6,215,195	122,154	+11.7%	Shares	Sole	2026-02-05
2025-09-30	$6,066,499	109,326	+101.0%	Shares	Sole	2025-11-13
2025-06-30	$3,753,168	54,378	+64.1%	Shares	Sole	2025-07-30
2025-03-31	$2,300,616	33,131	+73.1%	Shares	Defined	2025-05-07
2024-12-31	$1,646,422	19,140	+37.5%	Shares	Defined	2025-02-13
2024-09-30	$1,657,454	13,920	-4.8%	Shares	Defined	2024-11-05
2024-06-30	$2,087,144	14,622	+136.5%	Shares	Defined	2024-08-12
2023-12-31	$639,527	6,182	+7.4%	Shares	Defined	2024-02-14
2023-09-30	$523,268	5,754	+121.3%	Shares	Defined	2023-12-04
2023-03-31	$413,764	2,600	—	Shares	Defined	2023-05-11
No filing history on record for this holder in this stock.